Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.

Integer acquires medical device specialists with experience in structural heart, electrophysiology for $140M

Integer's estimated 2023 sales nearly reached $1.6 billion, up 16% compared to 2022. According to the company's statement, this acquisition helps expand its footprint in several key markets. 

January 17, 2024
Self-expandable TAVR cusp-overlap ICE

ICE guidance reduces risk of permanent pacemaker implantation after TAVR with a self-expandable valve

Heart teams can limit the risk of conduction disturbances that lead to permanent pacemaker implantation by utilizing both the cusp-overlap method and intracardiac echocardiography.

January 17, 2024
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.

Valve-in-valve TAVR an effective tool for treating structural valve degeneration after SAVR

With heart teams performing valve-in-valve TAVR more and more, researchers wanted to take a fresh look at patient outcomes. Overall, they found, the procedure was linked to a low mortality rate and fewer permanent pacemakers than native-valve TAVR.

January 16, 2024

Preventing blood clots after TMVR—what is the best anticoagulant for the job?

Choosing between DOACs and VKAs could make a significant impact on patient outcomes, according to new findings published in the Journal of the American College of Cardiology.

January 15, 2024
TAVR after mitral valve replacement

TAVR after mitral valve replacement linked to positive outcomes, but heart teams must plan ahead

Researchers in India performed TAVR on two relatively young patients with a preexisting mechanical mitral valve, sharing their experience in a new case report. The group highlighted the importance of planning ahead.

January 10, 2024
Cardiologist Roberto Canessa, MD, was just 19 when the plane he was on—Uruguayan Air Force Flight 571—crashed in the Andes in 1972. He and another survivor trekked in the cold for 38 miles to find help, leading to the group's rescue.  Image courtesy of https://robertocanessa.com.

Bravery of Andes plane crash survivor, now a pediatric cardiologist, on display in Netflix film ‘Society of the Snow’

Cardiologist Roberto Canessa, MD, was just 19 when the plane he was on—Uruguayan Air Force Flight 571—crashed in the Andes in 1972. He and another survivor trekked in the cold for 38 miles to find help, leading to the group's rescue. 

January 9, 2024
transesophageal echocardiography (TEE)

New expert guidelines: Start PHV evaluations with echocardiography, but other imaging modalities can provide value

New guidelines from the American Society of Echocardiography, made in collaboration with the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography, represent an update of the group's original recommendations from 2009.

January 9, 2024
Occlutech, a Swedish medical device company focused on structural heart disease, received U.S. Food and Drug Administration (FDA) approval in January 2024 for its ASD occluder for the treatment of atrial septal defects (ASDs).

Occlutech gains FDA approval for occluder device for atrial septal defects

According to CEO Sabine Bois, a veteran of the medical device industry, this approval represents a "significant leap forward" in the company's commitment to heart patients. 

January 8, 2024
Displaying 49 - 56 of 1144

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup